Delivery Order SPE2DB22D2006-SPE2DB25FW3DP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Mucus Relief DM ER 600-30 mg tablets (40-count package) with a ceiling value of $2,917.37. This is a firm fixed-price delivery order with a completion date of October 20, 2025, issued with no set-aside designation under competitive procurement procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count packaging) with a ceiling value of $1,573.01. This firm fixed-price delivery order is scheduled for ultimate completion by July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $1,383.61 to AmerisourceBergen Drug Corp for the supply of Mucus Relief DM ER 600-30 mg tablets (40 count). The award, issued on December 1, 2025, with completion expected by December 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $2,963.45. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucus Relief ER 600 mg tablets (500-count packages) with a ceiling value of $1,150.23. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, was structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance of this contract is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mucus Relief ER 600 mg tablets in unit dose packaging (100 count) with a contract value of $2,846.14. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, valued at $2,271.04, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,610.76 for 500 tablets of Mucus Relief ER 600 mg, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 8, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count). The order, valued at $6,729.58, represents a firm fixed-price delivery order with an ultimate completion date of September 9, 2025. This award was not designated as a set-aside contract and was competitively awarded through open competition. The product will be delivered to the place of performance in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,318.09 by the Defense Logistics Agency on August 18, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count containers). The contract is characterized as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and was awarded on a competitive basis without set-aside designation. Performance will occur at...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3DPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,030.42 to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Mucus Relief DM ER 600-30 mg tablets in quantities of 20 units. This firm fixed-price, non-set-aside contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad portfolio of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. The competitive award reflects the contractor's established capability to meet federal medical procurement requirements through open competition, consistent with its extensive history of delivery orders ranging from small-value transactions to substantial orders across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/6/25 |